Purification of the Antigenic Components of Pigeon Dropping Extract, the Responsible Agent for Cellular Immunity in Pigeon Breeder's Disease
Overview
Affiliations
Background: Pigeon breeder's disease (PBD) is a lung disease caused by inhalation of antigens derived from pigeons.
Objective: This study was undertaken to characterize the responsible component of pigeon dropping extract (PDE) for PBD.
Methods: First, crude PDE was applied to SDS-PAGE followed by immunoblotting by using antibodies in bronchoalveolar lavage (BAL) fluid. Second, 9 bands of PDE were separated by SDS-PAGE and used for antigen-induced PBMCs. Finally, amino-terminal sequencing was conducted on an isolated 21-kd protein by 2-dimensional electrophoresis.
Results: Immunoblots with BAL fluid from patients with PBD identified 9 bands. Similar patterns were observed by using BAL fluid from 10 control patients (9 with summer-type hypersensitivity pneumonitis or idiopathic pulmonary fibrosis and 1 asymptomatic breeder), except for the 21-kd protein, which was detected in 10 patients with PBD and 1 asymptomatic breeder. The stimulation indices of PBMCs determined by using proteins electroeluted from the 9 bands were higher in patients with PBD than in the 10 control patients. The 21-kd protein was separated into 5 spots by 2-dimensional electrophoresis; these spots were all reactive with BAL fluid from patients with PBD as determined by immunoblotting. The sequence of the 21-kd protein had 57% identity to a Saccharomyces cerevisiae chromosome X reading frame. A synthetic peptide, derived from the amino acid sequence of the N-terminal of the native protein, induced significant proliferation of PBMCs obtained from 5 patients with PBD, but not with PBMCs obtained from control patients.
Conclusion: The 21-kd protein is the only protein that identified individuals exposed to pigeons by immunoblotting. Only PBMCs from patients with PBD showed significant proliferation to the 21-kd protein and to the synthetic peptide on the basis of the N-terminal sequence of the native peptide. The 21-kd protein will be an important antigen for studies on the epidemiology, diagnosis, and pathogenesis of PBD.
A Sensitive Approach to Managing Hypersensitivity Pneumonitis.
Ahlawat P, Upadhyay P, Madaan P Cureus. 2022; 14(9):e29738.
PMID: 36340528 PMC: 9621725. DOI: 10.7759/cureus.29738.
Raghu G, Remy-Jardin M, Ryerson C, Myers J, Kreuter M, Vasakova M Am J Respir Crit Care Med. 2020; 202(3):e36-e69.
PMID: 32706311 PMC: 7397797. DOI: 10.1164/rccm.202005-2032ST.
Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management.
Kouranos V, Jacob J, Nicholson A, Renzoni E J Clin Med. 2017; 6(6).
PMID: 28617305 PMC: 5483872. DOI: 10.3390/jcm6060062.
Hypersensitivity pneumonitis: a complex lung disease.
Sforza G, Marinou A Clin Mol Allergy. 2017; 15:6.
PMID: 28286422 PMC: 5339989. DOI: 10.1186/s12948-017-0062-7.
Park H, Kim H, Chung D Immune Netw. 2010; 10(1):26-34.
PMID: 20228933 PMC: 2837154. DOI: 10.4110/in.2010.10.1.26.